We are proud to announce the birth of the new Pharma Division of GEA: GEA
Pharma Systems. We believe that this closer collaboration will enable us to
communicate with you more directly, address your questions faster and
participate in your future projects and studies more efficiently.
The Passion of Uniting People...
GEA Pharma Systems, formerly Niro Pharma Systems, unites more than 750
people with a clear pharma engineering passion, providing an advanced
one-stop-shop for solid and liquid dosage technology. GEA Pharma Systems is the
world leader in advanced solid dose processing for the pharmaceutical industry.
We unite the state-of-the-art technologies of Aeromatic, Buck,
Collette, Courtoy, Fielder, Lyophil and Niro to combine innovative
development and inspired engineering within our entire product range, from
individual pieces of equipment to complete process lines.
Innovation
Tomorrow’s technology today
For GEA Pharma Systems, innovation is the key to our success and to
continued prosperity for our customers. In fact it’s more than that. We know
that by continually stretching the boundaries of what is possible in
pharmaceutical processing we have the ability to support our Customers in
enhancing the opportunities available to millions of people all over the world.
This is what drives our business.
Our innovation takes many forms and
affects all parts of the process. We innovate to increase production and reduce
costs, to improve containment and safeguard the workforce, to achieve better
clinical effectiveness and to enhance quality control. At GEA Pharma Systems
the innovation never stops – it’s just part of what we do.
For example
we have pioneered Pharma Spray Drying to provide unprecedented
control of particle form and release profile for drug development, meeting the
most demanding clinical needs. FlexStream™: our new fluid bed
coating system offers multiple processing from a single bowl providing both
flexibility and cost benefits. MODUL™ and
Performa™ tablet presses combine unrivalled containment with
fast product change-over and high productivity. The Buck® MC
Valve makes the contained handling of active pharmaceutical
ingredients much easier and less expensive than has been possible in the past.
Consigma™: a unique continuous granulation and drying process
that drastically reduces time to market of new medicines and enables the move
to a 6-Sigma process; and PharmaConnect™ which enables diverse
GEA development equipment to be docked into a single ‘plug and play’ module
with full cGMP compliance.
Innovation - not just for its own sake but
for improved products, greater safety and enhanced productivity to deliver a
better future.